We co-cultured in vitro purified “healthy” panDCs (mixture of the three DC subsets from HD blood) with tumor cells or tumor-derived supernatants for 2 or 20 hours and subsequently evaluated CLR expression on DC subsets by flow cytometry (Figure 4A). Here, DCLK3 is linked to neoplasm.